These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 35536636)

  • 21. Analyses of reported severe adverse events after immunization with SARS-CoV-2 vaccines in the United States: One year on.
    Mangat HS; Musah A; Luedtke S; Syed AA; Maramattom BV; Maruthanal J; Bosman A; Kostkova P
    Front Public Health; 2022; 10():972464. PubMed ID: 36311588
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Safety Profile and Low Risk of Disease Relapse After BNT162b2 mRNA SARS-CoV-2 Vaccination in Patients With Rare Rheumatic Diseases.
    Fornaro M; Venerito V; Iannone F; Cacciapaglia F
    J Rheumatol; 2022 Mar; 49(3):334-335. PubMed ID: 35033998
    [No Abstract]   [Full Text] [Related]  

  • 23. New-onset myasthenia gravis after mRNA SARS-CoV-2 vaccination: a case series.
    Fanella G; Baiata C; Candeloro E; Toscano G; Colnaghi S; Mauri M; Cariddi LP; Rebecchi V; Solazzo F; Banfi P; Piatti M; Ferrarese C; Versino M
    Neurol Sci; 2022 Oct; 43(10):5799-5802. PubMed ID: 35870026
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Response to: The diagnosis of central retinal artery occlusion after mRNA-SARS-CoV-2 vaccination.
    Ikegami Y; Numaga J; Okano N; Fukuda S; Yamamoto H; Terada Y
    QJM; 2022 Dec; 115(12):882-883. PubMed ID: 35088865
    [No Abstract]   [Full Text] [Related]  

  • 25. Neuralgic amyotrophy following COVID-19 mRNA vaccination.
    Koh JS; Goh Y; Tan BY; Hui AC; Hoe RHM; Makmur A; Kei PL; Vijayan J; Ng KWP; Quek AML; Thirugnanm U
    QJM; 2021 Nov; 114(7):503-505. PubMed ID: 34347105
    [No Abstract]   [Full Text] [Related]  

  • 26. Acute Myocarditis Following COVID-19 mRNA Vaccination in Adults Aged 18 Years or Older.
    Simone A; Herald J; Chen A; Gulati N; Shen AY; Lewin B; Lee MS
    JAMA Intern Med; 2021 Dec; 181(12):1668-1670. PubMed ID: 34605853
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Equivalent humoral and cellular immune response but different side effect rates following SARS-CoV-2 vaccination in peritoneal and haemodialysis patients using messenger RNA vaccines.
    Stumpf J; Klimova A; Mauer R; Steglich A; Gembardt F; Martin H; Glombig G; Frank K; Tonn T; Hugo C
    Nephrol Dial Transplant; 2022 Mar; 37(4):796-798. PubMed ID: 34791446
    [No Abstract]   [Full Text] [Related]  

  • 28. Humoral Immune Response Following SARS-CoV-2 mRNA Vaccination and Infection in Pediatric-Onset Multiple Sclerosis.
    Breu M; Lechner C; Schneider L; Tobudic S; Winkler S; Siegert S; Baumann M; Seidl R; Berger T; Kornek B
    Pediatr Neurol; 2023 Jun; 143():19-25. PubMed ID: 36966598
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Myocarditis Associated with mRNA COVID-19 Vaccination.
    Starekova J; Bluemke DA; Bradham WS; Grist TM; Schiebler ML; Reeder SB
    Radiology; 2021 Nov; 301(2):E409-E411. PubMed ID: 34282971
    [No Abstract]   [Full Text] [Related]  

  • 30. Cardiac Complications After SARS-CoV-2 Infection and mRNA COVID-19 Vaccination - PCORnet, United States, January 2021-January 2022.
    Block JP; Boehmer TK; Forrest CB; Carton TW; Lee GM; Ajani UA; Christakis DA; Cowell LG; Draper C; Ghildayal N; Harris AM; Kappelman MD; Ko JY; Mayer KH; Nagavedu K; Oster ME; Paranjape A; Puro J; Ritchey MD; Shay DK; Thacker D; Gundlapalli AV
    MMWR Morb Mortal Wkly Rep; 2022 Apr; 71(14):517-523. PubMed ID: 35389977
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Type 1 diabetes mellitus following SARS-CoV-2 mRNA vaccination.
    Aydoğan Bİ; Ünlütürk U; Cesur M
    Endocrine; 2022 Oct; 78(1):42-46. PubMed ID: 35809159
    [TBL] [Abstract][Full Text] [Related]  

  • 32. BNT162b2 mRNA SARS-CoV-2 vaccination does not cause upregulation of endothelial activation markers or hypercoagulability: A prospective, single-arm, longitudinal study.
    Lim XR; Leung BP; Sum CLL; Lim GH; Chua CG; Tu TM; Ramanathan K; Huang MY; Howe HS; Fan BE
    Am J Hematol; 2022 Apr; 97(4):E141-E144. PubMed ID: 35015303
    [No Abstract]   [Full Text] [Related]  

  • 33. Transverse Myelitis Following SARS-CoV-2 Vaccination: A Pharmacoepidemiological Study in the World Health Organization's Database.
    Nguyen S; Bastien E; Chretien B; Sassier M; Defer G; Nehme A; Lelong-Boulouard V; Alexandre J; Fedrizzi S; Morice PM
    Ann Neurol; 2022 Dec; 92(6):1080-1089. PubMed ID: 36054163
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An Argentinean cohort of patients with rheumatic and immune-mediated diseases vaccinated for SARS-CoV-2: the SAR-CoVAC Registry-protocol and preliminary data.
    Isnardi CA; Schneeberger EE; Kreimer JL; Luna PC; Echeverría C; Roberts K; de la Vega MC; Virasoro BM; Landi M; Quintana R; Exeni MED; Kogan N; Petkovic I; Pereira D; De Los Ángeles Correa M; Zelaya MD; Tissera Y; Elkin MSG; Pisoni CN; Alonso C; Cogo AK; Cosatti MA; García L; Retamozo C; de Los Ángeles Severina M; Nieto RE; Rosemffet M; Mussano E; Bertoli A; Savio VG; Cosentino V; Pons-Estel GJ
    Clin Rheumatol; 2022 Oct; 41(10):3199-3209. PubMed ID: 35760939
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Oncologist counseling practice and COVID-19 vaccination outcomes for patients with history of PEG-asparaginase hypersensitivity.
    Zarnegar-Lumley S; Stone CA; Smith CM; Hall LL; Luck KE; Koo G; Plager JH; Phillips EJ; Friedman DL
    Pediatr Blood Cancer; 2022 Jul; 69(7):e29686. PubMed ID: 35353440
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Incidence of new onset glomerulonephritis after SARS-CoV-2 mRNA vaccination is not increased.
    Diebold M; Locher E; Boide P; Enzler-Tschudy A; Faivre A; Fischer I; Helmchen B; Hopfer H; Kim MJ; Moll S; Nanchen G; Rotman S; Saganas C; Seeger H; Kistler AD
    Kidney Int; 2022 Dec; 102(6):1409-1419. PubMed ID: 36096267
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Four cases of acquired hemophilia A following immunization with mRNA BNT162b2 SARS-CoV-2 vaccine.
    Leone MC; Canovi S; Pilia A; Casali A; Depietri L; Fasano T; Colla R; Ghirarduzzi A
    Thromb Res; 2022 Mar; 211():60-62. PubMed ID: 35081484
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Uveitis and Posterior Ophthalmic Manifestations Following the SARS-CoV-2 (COVID-19) Vaccine.
    Patel KG; Hilton T; Choi RY; Abbey AM
    Ocul Immunol Inflamm; 2022 Jul; 30(5):1142-1148. PubMed ID: 35763603
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Real-world data on the incidence and risk of Guillain-Barré syndrome following SARS-CoV-2 vaccination: a prospective surveillance study.
    Ha J; Park S; Kang H; Kyung T; Kim N; Kim DK; Kim H; Bae K; Song MC; Lee KJ; Lee E; Hwang BS; Youn J; Seok JM; Park K
    Sci Rep; 2023 Mar; 13(1):3773. PubMed ID: 36882454
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Adenoviral Vector DNA- and SARS-CoV-2 mRNA-Based Covid-19 Vaccines: Possible Integration into the Human Genome - Are Adenoviral Genes Expressed in Vector-based Vaccines?
    Doerfler W
    Virus Res; 2021 Sep; 302():198466. PubMed ID: 34087261
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.